SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Divi’s Laboratories concludes inspection at Visakhapatnam facility with no critical observations

04 Aug 2017 Evaluate

Divi’s Laboratories has successfully completed inspection carried out by 5 inspectors from HRPA (Ireland) and JAZMP (Slovenia) at its Unit-2 Visakhapatnam facility with no critical observations. The inspection was carried out between July 31, 2017 and August 4, 2017.

The inspection was focused on follow up on the effectiveness of the CAPA’s implemented from the last JAZMP inspection and general GMP inspection of the site.

Divi’s Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. The company in a matter of short time expanded its breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry.


Divis Lab Share Price

6281.35 52.40 (0.84%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×